Keywords: mgi, initiates, phase, irofulven/gemzar, trial, pharma, announced

MGI initiates Phase I irofulven/Gemzar trial

Article | 21 June 2001

Print This

MGI Pharma has announced the initiation of a dose-escalating Phase Iclinical trial of its novel anticancer compound irofulven in combination ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in